229 related articles for article (PubMed ID: 21147555)
21. Triple vessel stenting for triple vessel coronary disease.
Villegas B; Morice MC; Hernandez S; Choussat R; Dumas P; Lefevre T; Louvard Y; Loubeyre C; Fajadet J; Marco J
J Invasive Cardiol; 2002 Jan; 14(1):1-5. PubMed ID: 11773686
[TBL] [Abstract][Full Text] [Related]
22. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).
Vignali L; Saia F; Manari A; Santarelli A; Rubboli A; Varani E; Piovaccari G; Menozzi A; Percoco G; Benassi A; Rusticali G; Marzaroli P; Guastaroba P; Grilli R; Maresta A; Marzocchi A
Am J Cardiol; 2008 Apr; 101(7):947-52. PubMed ID: 18359313
[TBL] [Abstract][Full Text] [Related]
24. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.
Dreifaldt M; Mannion JD; Bodin L; Olsson H; Zagozdzon L; Souza D
Ann Thorac Surg; 2013 Jul; 96(1):105-11. PubMed ID: 23684156
[TBL] [Abstract][Full Text] [Related]
25. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
[TBL] [Abstract][Full Text] [Related]
26. Extensive endarterectomy of the left anterior descending coronary artery combined with coronary artery bypass grafting.
Christenson JT; Simonet F; Schmuziger M
Coron Artery Dis; 1995 Sep; 6(9):731-7. PubMed ID: 8747879
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of native artery versus bypass graft intervention in prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction.
Liu W; Liu YY; Mukku VK; Shi DM; Lü SZ; Zhou YJ
Chin Med J (Engl); 2013 Jun; 126(12):2281-5. PubMed ID: 23786939
[TBL] [Abstract][Full Text] [Related]
28. Peri-procedural outcome of saphenous vein graft intervention.
Shakoor T; Mallick NH; Noeman A
J Ayub Med Coll Abbottabad; 2012; 24(3-4):39-42. PubMed ID: 24669605
[TBL] [Abstract][Full Text] [Related]
29. Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial.
Hayward PA; Hare DL; Gordon I; Buxton BF
Eur J Cardiothorac Surg; 2008 Jul; 34(1):113-7. PubMed ID: 18455416
[TBL] [Abstract][Full Text] [Related]
30. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
[TBL] [Abstract][Full Text] [Related]
31. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries.
Quan VH; Huynh R; Seifert PA; Kuchela A; Chen WH; Sütsch G; Eisenhauer AC; Rogers C
Am J Cardiol; 2005 Jun; 95(12):1415-9. PubMed ID: 15950562
[TBL] [Abstract][Full Text] [Related]
32. Flow capacity of internal mammary artery grafts: early restriction and later improvement assessed by Doppler guide wire. Comparison with saphenous vein grafts.
Akasaka T; Yoshikawa J; Yoshida K; Maeda K; Hozumi T; Nasu M; Shomura T
J Am Coll Cardiol; 1995 Mar; 25(3):640-7. PubMed ID: 7860908
[TBL] [Abstract][Full Text] [Related]
33. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention.
Fischell TA; Subraya RG; Ashraf K; Perry B; Haller S
J Invasive Cardiol; 2007 Feb; 19(2):58-62. PubMed ID: 17268038
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE;
Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037
[TBL] [Abstract][Full Text] [Related]
35. Manual aspiration prior to stenting does not reduce the incidence of filter no reflow in saphenous vein graft lesions protected by FilterWire EX/EZ.
Jim MH; Yiu KH; Ko RL; Ho HH; Siu CW; Chow WH
Acute Card Care; 2010 Sep; 12(3):92-5. PubMed ID: 20677906
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
[TBL] [Abstract][Full Text] [Related]
37. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
[TBL] [Abstract][Full Text] [Related]
38. Choice of conduit for the right coronary system: 8-year analysis of Radial Artery Patency and Clinical Outcomes trial.
Hadinata IE; Hayward PA; Hare DL; Matalanis GS; Seevanayagam S; Rosalion A; Buxton BF
Ann Thorac Surg; 2009 Nov; 88(5):1404-9. PubMed ID: 19853082
[TBL] [Abstract][Full Text] [Related]
39. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
[TBL] [Abstract][Full Text] [Related]
40. Catastrophic consequences of internal mammary artery hypoperfusion.
Jones EL; Lattouf OM; Weintraub WS
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):902-7. PubMed ID: 2572732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
